population was at risk for anemia (low red blood cells or hemoglobin, often caused by iron deficiency) or at least one vitamin deficiency---meaning they fell below the deficiency cutoffs established from CDC data for at least one micronutrient
What microdosing does not mean Microdosing does not automatically mean fewer side effects, better brain protection, safer use, or a more advanced protocol
Personalization Beyond Price: Genetic Testing for Optimal GLP-1 Response PlexusDx distinguishes itself by integrating peptide-pathway genetic testing into treatment selection
This protection extends to potential benefits for inflammatory bowel conditions, such as Crohns disease and ulcerative colitis, although further clinical studies are needed
Additionally, while the total discontinuation rates were not reported, the proportion of patients receiving active treatment who discontinued due to adverse events was 10% in the LEADER trial of liraglutide (median follow-up 46 months) and 12% in the PIONEER 6 trial of oral semaglutide (median follow-up 15.9 months)